| Literature DB >> 34205708 |
Marie Tremblay-Franco1,2, Cécile Canlet1,2, Philippe Pinton1, Yannick Lippi1, Roselyne Gautier1,2, Claire Naylies1, Manon Neves1, Isabelle P Oswald1, Laurent Debrauwer1,2, Imourana Alassane-Kpembi3.
Abstract
The effects of low doses of toxicants are often subtle and information extracted from metabolomic data alone may not always be sufficient. As end products of enzymatic reactions, metabolites represent the final phenotypic expression of an organism and can also reflect gene expression changes caused by this exposure. Therefore, the integration of metabolomic and transcriptomic data could improve the extracted biological knowledge on these toxicants induced disruptions. In the present study, we applied statistical integration tools to metabolomic and transcriptomic data obtained from jejunal explants of pigs exposed to the food contaminant, deoxynivalenol (DON). Canonical correlation analysis (CCA) and self-organizing map (SOM) were compared for the identification of correlated transcriptomic and metabolomic features, and O2-PLS was used to model the relationship between exposure and selected features. The integration of both 'omics data increased the number of discriminant metabolites discovered (39) by about 10 times compared to the analysis of the metabolomic dataset alone (3). Besides the disturbance of energy metabolism previously reported, assessing correlations between both functional levels revealed several other types of damage linked to the intestinal exposure to DON, including the alteration of protein synthesis, oxidative stress, and inflammasome activation. This confirms the added value of integration to enrich the biological knowledge extracted from metabolomics.Entities:
Keywords: metabolomics 3; mycotoxin exposure 1; statistical integration 4; transcriptomics 2
Year: 2021 PMID: 34205708 PMCID: PMC8233929 DOI: 10.3390/metabo11060407
Source DB: PubMed Journal: Metabolites ISSN: 2218-1989
Figure 1Two-dimensional PLS-DA (R2 = 95% and Q2 = 0.91) score plot of the integrated 1H NMR spectra of jejunum explant extracts (control, n = 8, light blue dot; DON-exposed, n = 8, dark blue dot). Each dot corresponds to an individual.
Figure 2Comparison of metabolites found to be discriminant by PLS-DA (upper line), Robust sparse CCA+O2-PLS-DA (middle line), or SOM+O2-PLS-DA (lower line).
Figure 3Two-dimensional PLS-DA (R2 = 95% and Q2 = 0.91) score plot of transcriptomic data generated from jejunum explant extracts (control, n = 8, light blue dot; DON-exposed, n = 8, dark blue dot). Each dot corresponds to an individual.
Figure 4Projection of individuals along the first latent variable of the O2-PLS-DA model based on the features selected by rsCCA (light blue dot: control, n = 8; dark blue dot: exposed, n = 8). Each dot corresponds to an individual. (a) Transcriptomic dataset; (b) metabolomic dataset.
Figure 5Projection of individuals along the first latent variable of the O2-PLS-DA model based on the features selected by dissimilarity kernel-based SOM (light blue dot: control, n = 8; dark blue dot: exposed, n = 8). Each dot corresponds to an individual. (a) Transcriptomic dataset; (b) metabolomic dataset.
Metabolic pathways significantly enriched in DON-exposed intestinal explants.
| Pathway Name | Number of Mapped Metabolites | Coverage (%) | BH-Corrected |
|---|---|---|---|
| Aminoacyl-tRNA biosynthesis | 10 | 21.3 | 1.73 × 10−9 |
| Biosynthesis of amino acids | 8 | 12.7 | 9.48 × 10−6 |
| Alanine, aspartate and glutamate metabolism | 5 | 15.2 | 5.79 × 10−4 |
| Arginine biosynthesis | 3 | 21.4 | 5.18 × 10−3 |
| Phenylalanine, tyrosine and tryptophan biosynthesis | 2 | 50.0 | 6.48 × 10−3 |
| D-Glutamine and D-glutamate metabolism | 2 | 40.0 | 9.18 × 10−3 |
| Nitrogen metabolism | 2 | 33.3 | 0.01 |
| 2-Oxocarboxylic acid metabolism | 3 | 14.3 | 0.01 |
| Valine, leucine and isoleucine biosynthesis | 2 | 25.0 | 0.018 |
Figure 6Correlations between the discriminant metabolites and transcriptomic features. Meaning of transcriptomics features (columns): 1: IL-1α.1; 2: IL-1α.3; 3: IL-1α.2; 4: IL-1β.2; 5: IL-1β; 6: IL-1β.1; 7: IL10.2; 8: IL10.1; 9: IL10.3; 10: SOCS3.1; 11: SOCS3.2; 12: IL4R.1; 13: SOCS3.3; 14: CXCL2.1; 15: CXCL2.2; 16: IL8.3; 17: IL8.2; 18: IL8.1; 19: IL8.4; 20: IL22; 21: IL17A; 22: IL23A; 23: CXCL2.3; 24: TXNIP.3; 25: TXNIP.2; 26: TXNIP.1; 27: TXNIP.10; 28: TXNIP.9; 29: TXNIP.8; 30: TXNIP.6; 31: TXNIP.4; 32: TXNIP.5; 33: TXNIP.7; 34: TXNIP.11; 35: IL4R.2; 36: IL6.3; 37: IL6.2; 38: IL6.4; 39: IL6.1; 40: CYP1A1; 41: SOD2; 42: CX060127; 43: CYP3A29.2; 44: CYP3A29.1; 45: GCG; 46: CYBRD1.1; 47: CYBRD1.2.